The funding helps CMR Surgical’s valuation hit the $3B mark. Here are the top-line bullets you need to know.
CMR Surgical, a surgical robotics company, has raised $600M in a Series D with participation from SoftBank Group, Ally Bridge Group, Tencent Holdings, and GE Healthcare, among others.
How’s the company performing?
- UK-based CMR Surgical’s surgical robot, Versius, is designed to perform minimally invasive surgical procedures. Versius has a modular and portable system, offering 3D HD vision, instrument control, and ergonomic positions.
- Versius has been launched across geographies such as Europe, India, Australia, and the Middle East.
Source: CMR Surgical
Why does the market matter?
- The global surgical robots market is projected to grow at a CAGR of 17.6% to reach a value of 14.4B by 2026, according to Markets and Markets.
- Deals to robotic surgery startups nearly doubled between 2015 and 2019, but funding peaked at $638M in 2017. In just 15 years, the number of players applying for robotic surgery-related patents increased by more than 30x. Application volume also skyrocketed, growing nearly 70x over the same period.